[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336217-105":59,"doc-detail-336217-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","nanomaterials-induced-redox-imbalance-challenged-and-opportunities-for-nanomaterials-in-cancer-therapy","Nanomaterials-Induced Redox Imbalance - Challenged and Opportunities for Nanomaterials in Cancer Therapy","","Nanomaterials-Induced Redox Imbalance reviews how cancer cells develop redox imbalance through heightened metabolism, mitochondrial dysfunction, dysregulated signaling, and increased peroxisomal activity. It explains how this imbalance can control gene expression, protein stability, and cellular programs, often making conventional treatments less effective. The review outlines redox thresholds that can trigger programmed cell death and discusses nanotechnology strategies to modulate intracellular and extracellular redox states to improve selectivity and overcome therapy resistance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nanomaterials-induced-redox-imbalance-challenged-and-opportunities-for-nanomaterials-in-cancer-therapy/336217/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nanomaterials-induced-redox-imbalance-challenged-and-opportunities-for-nanomaterials-in-cancer-therapy/336217.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why do cancer cells show redox imbalance compared with normal cells?","Question",{"text":112,"@type":113},"Cancer cells typically experience redox imbalance due to increased metabolic rate, mitochondrial dysfunction, elevated cell signaling, and accelerated peroxisomal activities.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How can redox imbalance be exploited to improve cancer treatment?",{"text":117,"@type":113},"Therapies that target intracellular or extracellular redox states at different progression stages can push cancer cells beyond a threshold to trigger programmed cell death while enhancing therapeutic selectivity and helping overcome resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"What roles do nanomaterials play in redox-based cancer therapy?",{"text":121,"@type":113},"Nanotechnology enables modulation of redox states because nanomaterials are highly designable and reactive, including approaches that enhance reactive species generation, disrupt endogenous antioxidant defenses, or both.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336217,1790734919,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","REVIEW  \n[www.advancedscience.com](www.advancedscience.com)  \nNanomaterials-Induced Redox Imbalance: Challenged and Opportunities for Nanomaterials in Cancer Therapy  \nXumeng Wu, Ziqi Zhou, Kai Li, and Shaoqin Liu*  \nCancer cells typically display redox imbalance compared with normal cells due to increased metabolic rate, accumulated mitochondrial dysfunction, elevated cell signaling, and accelerated peroxisomal activities. This redox imbalance may regulate gene expression, alter protein stability, and modulate existing cellular programs, resulting in ineﬃcient treatment modalities. Therapeutic strategies targeting intra-or extracellular redox states of cancer cells at varying state of progression may trigger programmed cell death if exceeded a certain threshold, enabling therapeutic selectivity and overcoming cancer resistance to radiotherapy and chemotherapy. Nanotechnology provides new opportunities for modulating redox state in cancer cells due to their excellent designability and high reactivity. Various nanomaterials are widely researched to enhance highly reactive substances (free radicals) production, disrupt the endogenous antioxidant defense systems, or both. Here, the physiological features of redox imbalance in cancer cells are described and the challenges in modulating redox state in cancer cells are illustrated. Then, nanomaterials that regulate redox imbalance are classiﬁed and elaborated upon based on their ability to target redox regulations. Finally, the future perspectives in this ﬁeld are proposed. It is hoped this review provides guidance for the design of nanomaterials-based approaches involving modulating intra-or extracellular redox states for cancer therapy, especially for cancers resistant to radiotherapy or chemotherapy, etc.  \n1. Introduction  \nCancer remains a leading cause of death worldwide. [1] Despite the advancements in cancer treatment modalities, the genetic heterogeneity, diversity, and complexity of tumors pose daunting challenges for developing more eﬃcient and eﬀective cancer therapies. [2] Abundant data revealed that cancer cells experience oxidative stress during certain critical phases of their evolutionary and progressive stages. [3] Mechanisms leading to oxidative stress in cancer cells may involve hyperactivation of anabolic pathways,[4] increased mitochondrial function,[5] malfunction of the electron transport chain (ETC) as a result of mitochondrial DNA mutations,[6] and oncogenic pathway activation. [7] Consequently, cancer cells exhibit redox imbalance compared to normal cells and deploy a variety of antioxidant mechanisms to counterbalance the oxidative damage resulting from oxidative stress. These mechanisms include glutathione (GSH),[8] thioredoxin (Trx, aka TXN),[9] antioxidant enzymes (e.g., glutathione peroxidases (GPXs),[10] catalases (CATs),[11] and superoxide dismutases (SODs),[12] and their transcriptional  \nX. Wu, S. Liu  \nSchool of Life Science and Technology Harbin Institute of Technology  \nHarbin 150006, China  \nE-mail: [shaoqinliu@hit.edu.cn](shaoqinliu@hit.edu.cn)  \nX. Wu, Z. Zhou, K. Li, S. Liu Zhengzhou Research Institute Harbin Institute of Technology Zhengzhou 450046, China  \nZ. Zhou, K. Li, S. Liu  \nSchool of Medicine and Health Harbin Institute of Technology  \nHarbin 150006, China  \nThe ORCID identiﬁcation number(s) for the author(s) of this article  \ncan be found under [https://doi.org/10.1002/advs.202308632](https://doi.org/10.1002/advs.202308632)[ ](https://doi.org/10.1002/advs.202308632)© 2024 The Authors. Advanced Science published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nDOI: 10.1002/advs.202308632  \nregulators, such as the nuclear factor erythroid 2-related factor 2 (Nrf-2)[13] and BTB domain and CNC homolog 1 (BACH1) . [14] Therefore, employing redox-modulating strategi","cbCaig1Ze74rabF2","https://ap.wps.com/l/cbCaig1Ze74rabF2","pdf",31297981,39,"English","# Introduction\n## Oxidative stress and redox imbalance in cancer\n## Antioxidant defense systems and regulators\n## Redox-modulating therapeutic strategies\n## Limitations of conventional antioxidants and ROS-inducers","[{\"question\":\"Why do cancer cells show redox imbalance compared with normal cells?\",\"answer\":\"Cancer cells typically experience redox imbalance due to increased metabolic rate, mitochondrial dysfunction, elevated cell signaling, and accelerated peroxisomal activities.\"},{\"question\":\"How can redox imbalance be exploited to improve cancer treatment?\",\"answer\":\"Therapies that target intracellular or extracellular redox states at different progression stages can push cancer cells beyond a threshold to trigger programmed cell death while enhancing therapeutic selectivity and helping overcome resistance.\"},{\"question\":\"What roles do nanomaterials play in redox-based cancer therapy?\",\"answer\":\"Nanotechnology enables modulation of redox states because nanomaterials are highly designable and reactive, including approaches that enhance reactive species generation, disrupt endogenous antioxidant defenses, or both.\"}]","Nanomaterials-Induced Redox Imbalance - Challenged and Opportunities for Nanomaterials in Cancer Therapy | PDF",1790014154,98,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e59716ccb8dc1167bcff82da7722ba0.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a9d3b768f01db999c72726427100d75.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/00c8f1bdc04fdc5de40c9f6c47d4503c.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d06db7b0a715b2a181d095ed56d64e8a.webp",980,1287]